Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
7.36
-0.23
(-3.03%)
At close: February 24 at 4:00:00 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
19,185
20,405
6,657
--
Total Liabilities Net Minority Interest
6,984
6,186
17,665
10
Total Equity Gross Minority Interest
12,201
14,219
-11,008
-10
Total Capitalization
12,201
14,219
-11,008
-10
Common Stock Equity
12,201
14,219
-11,008
-10
Net Tangible Assets
12,201
14,219
-11,008
-10
Working Capital
12,201
14,219
3,414
-10
Invested Capital
12,201
14,219
-11,008
-10
Tangible Book Value
12,201
14,219
-11,008
-10
Share Issued
17,418.89
14,642.48
12,717.79
11,817.79
Ordinary Shares Number
17,418.89
14,642.48
12,717.79
11,817.79
12/31/2020 - 2/4/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DRTS Alpha Tau Medical Ltd.
2.7400
+2.24%
PSTV Plus Therapeutics, Inc.
1.1400
-2.56%
LRMR Larimar Therapeutics, Inc.
3.0300
-5.02%
FULC Fulcrum Therapeutics, Inc.
3.7000
-3.90%
DRMA Dermata Therapeutics, Inc.
1.2000
-4.00%
PTGX Protagonist Therapeutics, Inc.
36.00
-7.10%
COEP Coeptis Therapeutics Holdings, Inc.
9.89
-5.99%
LXEO Lexeo Therapeutics, Inc.
3.7300
-4.11%
ACRV Acrivon Therapeutics, Inc.
5.38
-2.89%
TCRX TScan Therapeutics, Inc.
2.1300
-1.84%